3 ms·
On one level I agree, but realistically I think they may not feel much of a hurry to do so since there isn't a significant supply ready to distribute. My under
by rossdavidh 5y ago
On one level I agree, but realistically I think they may not feel much of a hurry to do so since there isn't a significant supply ready to distribute. My understanding is that they already have authorization to use whatever they have, essentially as additional testing.
- loeg 5y agoAs of Nov 29, > Pfizer now expects to make 80 million courses of COVID drug Paxlovid by the end of 2022 That's a ton of supply!
- wiml 5y agoI'm not sure what you're quoting from, but ... that's more than a year from now.
- bsder 5y agoEnd of 2022. That doesn't help us in 2021.
- senectus1 5y agoto me its sounds like its too slow. how many variant have we had this year already? I hope the pill from pfizer can withstand the evolution cycle of this blasted virus.